Related Experiment Videos
[Levofloxacin in obstetrics and gynecology]
T Chimura1, N Morisaki, T Funayama
1Department of Obstetrics and Gynecology, School of Medicine, Yamagata University.
The Japanese Journal of Antibiotics
|May 1, 1992
Abstract:
We investigated the clinical efficacy and the safety of levofloxacin (LVFX, DR-3355) in obstetrical and gynecological infections and the following results were obtained. 1. Clinical efficacies were evaluated as excellent in 2 and good in 9 cases, hence the efficacy rate was 100%. 2. Bacteriologically, the eradication rate was 16/17 (94.1%). 3. No Side effects nor abnormal changes in laboratory test results were observed. These results indicated that LVFX was highly useful in the treatment of obstetrical and gynecological infections.